Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125618563 | 12561856 | 3 | F | 20130205 | 20160816 | 20160715 | 20160824 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-057126 | BRISTOL MYERS SQUIBB | 38.00 | YR | F | Y | 0.00000 | 20160824 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125618563 | 12561856 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 3 DF, QD | Y | 21436 | 3 | DF | TABLET | QD | |||||
| 125618563 | 12561856 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 6 MG, QD | Y | 21436 | 6 | MG | TABLET | QD | |||||
| 125618563 | 12561856 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 3 MG, UNK | Y | 21436 | 3 | MG | TABLET | QD | |||||
| 125618563 | 12561856 | 4 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 3 DF, UNK | Y | 21436 | 3 | DF | TABLET | ||||||
| 125618563 | 12561856 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | 4200 | MG | U | 0 | 40 | MG | TABLET | QD | |||
| 125618563 | 12561856 | 6 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, QD | 10500 | MG | U | 0 | 100 | MG | TABLET | QD | |||
| 125618563 | 12561856 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
| 125618563 | 12561856 | 8 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 3 MG, QD | Y | 0 | 3 | MG | TABLET | QD | |||||
| 125618563 | 12561856 | 9 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 6 MG, QD | Y | 0 | 6 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125618563 | 12561856 | 1 | Hyperphagia |
| 125618563 | 12561856 | 2 | Affect lability |
| 125618563 | 12561856 | 3 | Suicidal ideation |
| 125618563 | 12561856 | 5 | Product used for unknown indication |
| 125618563 | 12561856 | 6 | Product used for unknown indication |
| 125618563 | 12561856 | 7 | Product used for unknown indication |
| 125618563 | 12561856 | 8 | Hyperphagia |
| 125618563 | 12561856 | 9 | Affect lability |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125618563 | 12561856 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125618563 | 12561856 | Dyslalia | |
| 125618563 | 12561856 | Dysphagia | |
| 125618563 | 12561856 | Facial spasm | |
| 125618563 | 12561856 | Mastication disorder | |
| 125618563 | 12561856 | Physical disability | |
| 125618563 | 12561856 | Product use issue | |
| 125618563 | 12561856 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125618563 | 12561856 | 1 | 201302 | 0 | ||
| 125618563 | 12561856 | 2 | 20130216 | 20130726 | 0 | |
| 125618563 | 12561856 | 3 | 20121124 | 20130215 | 0 | |
| 125618563 | 12561856 | 4 | 201302 | 0 | ||
| 125618563 | 12561856 | 5 | 20121024 | 20130726 | 0 | |
| 125618563 | 12561856 | 6 | 20121024 | 20130726 | 0 | |
| 125618563 | 12561856 | 7 | 20121024 | 20121221 | 0 | |
| 125618563 | 12561856 | 8 | 20121124 | 20130215 | 0 | |
| 125618563 | 12561856 | 9 | 20130216 | 20130726 | 0 |